Complete Response Letter Issued from U.S. FDA for Investigational Long-Acting HIV Regimen
- Saturday, December 21, 2019, 7:48
- PR Newswire
- Add a comment
TITUSVILLE, N.J., Dec. 21, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) in response to ViiV Healthcare’s (ViiV) New Drug Application for the two-drug…
About the Author
admin has written 20655 stories on this site.